Rho��ø��о��չ

[1]

WIBBERLEY A�� CHEN Z�� HU E�� et al. Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle[J]. Br J Pharmacol�� 2003�� 138(5)�� 757-766. [2] NAKAGAWA O�� FUJISAWA K�� ISHIZAKI T�� et al. ROCK-I and ROCK-II�� two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice[J]. FEBS Lett�� 1996�� 392(2)�� 189-193. [3] HIROKI J�� SHIMOKAWA H�� HIGASHI M�� et al. Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells[J]. J Mol Cell Cardiol�� 2004�� 37(2)�� 537-546. [4] HIROKI J�� SHIMOKAWA H�� MUKAI Y�� et al. Divergent effects of estrogen and nicotine on Rho-kinase expression in human coronary vascular smooth muscle cells[J]. Biochem Biophys Res Commun�� 2005�� 326(1)�� 154-159. [5] KAWABATA S�� USUKURA J�� MORONE N�� et al. Interaction of Rho-kinase with myosin II at stress fibres[J]. Genes Cells�� 2004�� 9(7)�� 653-660. [6] SHIMIZU Y�� THUMKEO D�� KEEL J�� et al. ROCK-I Regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles[J]. J Cell Biol�� 2005�� 168(6)�� 941-953. [7] THUMKEO D�� KEEL J�� ISHIZAKI T�� et al. Targeted disruption of the mouse rho-associated kinase gene results in intrauterine growth retardation and fetal death[J]. Mol Cell Biol�� 2003�� 23(14)�� 5043-5055. [8] AMANO M�� FUKATA Y�� KAIBUCHI K. Regulation and functions of Rho-associated kinase[J]. Exp Cell Res�� 2000�� 261(1)�� 44-51. [9] DORAN J D�� LIU X�� TASLIMI P�� et al. New insights into the structure-function relationships of Rho-associated kinase�� a thermodynamic and hydrodynamic study of the dimer-to-monomer transition and its kinetic implications[J]. Biochem J�� 2004�� 384(2)�� 255-262. [10] SHIRAO S�� KASHIWAGI S�� SATO M�� et al. Sphingosylphosphorylcholine is a novel messenger for Rho-kinase-mediated Ca2+ sensitization in the bovine cerebral artery�� unimportant role for protein kinase C[J]. Circ Res�� 2002�� 91(2)�� 112-119. [11] SEBBAGH M�� RENVOIZE C�� HAMELIN J�� et al. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing[J]. Nat Cell Biol�� 2001�� 3(4)�� 346-352. [12] SEBBAGH M�� HAMELIN J�� BERTOGLIO J�� et al. Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner[J]. J Exp Med�� 2005�� 201(3)�� 465-471. [13] RIENTO K�� GUASCH R M�� GARG R�� et al. RhoE binds to ROCK I and inhibits downstream signaling[J]. Mol Cell Biol�� 2003�� 23(12)�� 4219-4229. [14] KITAZAWA T�� ETO M�� WOODSOME T P�� et al. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility[J]. J Biol Chem�� 2000�� 275(14)�� 9897-9900. [15] VAHEBI S�� KOBAYASHI T�� WARREN C M�� et al. Functional effects of rho-kinase-dependent phosphorylation of specific sites on cardiac troponin[J]. Circ Res�� 2005�� 96(7)�� 740-747. [16] LI Z�� DONG X�� WANG Z�� et al. Regulation of PTEN by Rho small GTPases[J]. Nat Cell Biol�� 2005�� 7(4)�� 399-404. [17] WOLFRUM S�� DENDORFER A�� RIKITAKE Y�� et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection[J]. Arterioscler Thromb Vasc Biol�� 2004�� 24(10)�� 1842-1847. [18] RIENTO K�� TOTTY N�� VILLALONGA P�� et al. RhoE function is regulated by ROCK I-mediated phosphorylation[J]. EMBO J�� 2005�� 24(6)�� 1170-1180. [19] SOMLYO A P�� SOMLYO A V. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II�� Modulated by G proteins�� kinases�� and myosin phosphatase[J]. Physiol Rev�� 2003�� 83(4)�� 1325-1358. [20] DUBROCA C�� YOU D�� LEVY B I�� et al. Involvement of RhoA/Rho kinase pathway in myogenic tone in the rabbit facial vein[J]. Hypertension�� 2005�� 45(5)�� 974-979. [21] MACK C P�� SOMLYO A V�� HAUTMANN M�� et al. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization[J]. J Biol Chem�� 2001�� 276(1)�� 341-347. [22] HIGASHI M�� SHIMOKAWA H�� HATTORI T�� et al. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo�� effect on endothelial NAD(P)H oxidase system[J]. Circ Res�� 2003�� 93(8)�� 767-775. [23] ZEIDAN A�� NORDSTROM I�� ALBINSSON S�� et al. Stretch-induced contractile differentiation of vascular smooth muscle�� sensitivity to actin polymerization inhibitors[J]. Am J Physiol Cell Physiol�� 2003�� 284(6)�� 1387-1396. [24] SUN X Z�� TIAN X Y. Expression of Rho kinase in lung tissue of rats with hypoxia pulmonary hypertension and its significance[J]. J Shanxi Med Univ(ɽ��ҽ�ƴ�ѧѧ��)�� 2010�� 41(12)�� 1022-1025. [25] LIU A J�� WANG D�� ZHU Y B�� et al. Inhibiting effect of Fasudil on human pulmonary artery smooth muscle cell proliferation[J]. J Chin Pract Diag Ther(�л�ʵ��־)�� 2011�� 25(1)�� 7-10. [26] KATO M�� lWAMOTO H�� HIGASHI N�� et al. Role of Rho small GTP binding protein in the regulation of actin cytoskeleton in hepatic stellate cells[J]. J Hepatol�� 1999�� 31(1)�� 91-99. [27] SU M�� MAN K�� HUANG Z�� et al. Activation of hepatic stellate cells in a cirrhotic rat liver transplantation model using small-for-size grafts�� The significance of Rho-ROCK signaling pathway[J]. Chin J Exp Surg (�л�ʵ��־) �� 2005�� 22(12)�� 1452-1454. [28] KAWAGUCHI A�� OHMORI M�� FUJIMURA A. Partial protective effect of Y-27632�� a Rho kinase inhibitor�� against hepatic ischemia-reperfusion injury in rats[J]. Eur J Pharmacol�� 2004�� 493(1-3)��167-171. [29] NAGATOYA K�� MORIYAMA T�� KAWADA N�� et al. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction[J]. Kidney Int�� 2002�� 61(5)�� 1684-1695. [30] BAO W�� HU E�� TAO L�� et al. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury[J]. Cardiovasc Res�� 2004�� 61(3)�� 548-558. [31] YADA T�� SHIMOKAWA H�� HIRAMATSU O�� et al. Beneficial effect of hydroxyfasudil�� a specific rho-Kinase inhibitor�� on ischemia/reperfusion injury in canine coronary microcirculation in vivo[J]. J Am Coll Cardiol�� 2005�� 45(4)�� 599-607. [32] DEMIRY�xREK S�� KARA A F�� CELIK A�� et al. Effects of Y-27632�� a selective Rho-kinase inhibitor�� on myocardial preconditioning in anesthetized rats[J]. Biochem Pharmacol�� 2005�� 69(1)�� 49-58. [33] BRABECK C�� MITTELBRONN M�� BEKURE K�� et al. Effect of focal cerebral infarctions on lesional RhoA and RhoB expression[J]. Arch Neurol�� 2003�� 60(9)�� 1245-1249. [34] YAMASHITA K�� KOTANI Y�� NAKAJIMA Y�� et al. Fasudil�� a Rho kinase (ROCK) inhibitor�� protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons[J]. Brain Res�� 2007�� 1154�� 215-224. [35] YANO K�� KAWASAKI K�� HATTORI T�� et al. Demonstration of elevation and localization of Rho-kinase activity in the brain of a rat model of cerebral infarction[J]. Eur J Pharmacol�� 2008�� 594(1-3)�� 77-83. [36] RIKITAKE Y�� KIM H H�� HUANG Z�� et al. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection[J]. Stroke�� 2005�� 36(10)�� 2251-2257. [37] LI Q�� HUANG X J�� HE W�� et al. Neuroprotective potential of fasudil mesylate in brain ischemia-reperfusion injury of rats[J]. Cell Mol Neurobiol�� 2009�� 29(2)�� 169-180. [38] HUANG L�� LI Q�� LI H�� et al. Inhibition of intracellular Ca2+ release by a Rho-kinase inhibitor for the treatment of ischemic damage in primary cultured rat hippocampal neurons[J]. Eur J Pharmacol�� 2009��602(2-3)�� 238-244. [39] LI Q�� LIU D�� HUANG X�� et al. Fasudil mesylate protects PC12 Cells from oxidative stress injury via the bax-mediated pathway[J]. Cell Mol Neurobiol�� 2010.[40] ZHENG Y�� SUN N�� XIONG Q�� et al. The role of specific ROCK inhibitor in the prevention of experimental PVR in rabbits[J]. Chin J Ophthalmol (�л��ۿ��־)�� 2005�� 41(12)�� 1112-1118. [41] YU Y�� XIN X�� WU W�� et al. The expression of Rho and ROCK protein in the epithallal ovarian carcinoma[J]. J Mod Oncol (�ִ��ҽѧ)�� 2006�� 14(4)�� 461-464. [42] WANG H�� CHEN Y�� LU J. Rho family expression in neoplasms and its clinical significance[J]. China Oncol(�й��֢��־)�� 2005�� 15(4)�� 399-401. [43] SHIMOKAWA H�� HIRAMORI K�� IINUMA H�� et al. Anti-anginal effect of fasudil�� a Rho-kinase inhibitor�� in patients with stable effort angina�� a multicenter study[J]. J Cardiovasc Pharmacol�� 2002�� 40(5)�� 751-761. [44] MOHRI M�� SHIMOKAWA H�� HIRAKAWA Y�� et al. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm[J]. J Am Coll Cardiol�� 2003�� 41(1)�� 15-19. [45] KISHI T�� HIROOKA Y�� MASUMOTO A�� et al. Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure[J]. Circulation�� 2005�� 111(21)�� 2741-2747. [46] FUKUMOTO Y�� MATOBA T�� ITO A�� et al. Acute vasodilator effects of a Rho-kinase inhibitor�� fasudil�� in patients with severe pulmonary hypertension[J]. Heart�� 2005�� 91(3)�� 391-392. [47] GONG L L�� FANG L H�� DU G H. New target for treatment of cardiovascular disease-Rho Kinase[J]. Chin Pharm J(�й�ҩѧ��־)�� 2008�� 43(1)�� 1-4. [48] LOIRAND G�� GU��RIN P�� PACAUD P. Rho kinases in cardiovascular physiology and pathophysiology[J]. Circ Res�� 2006�� 98(3)�� 322-334.